{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,6,1]],"date-time":"2026-06-01T15:54:25Z","timestamp":1780329265028,"version":"3.54.1"},"reference-count":22,"publisher":"Springer Science and Business Media LLC","issue":"2","license":[{"start":{"date-parts":[[2015,1,15]],"date-time":"2015-01-15T00:00:00Z","timestamp":1421280000000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Hepatol Int"],"published-print":{"date-parts":[[2015,4]]},"DOI":"10.1007\/s12072-014-9597-6","type":"journal-article","created":{"date-parts":[[2015,1,14]],"date-time":"2015-01-14T02:39:29Z","timestamp":1421203169000},"page":"202-208","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":35,"title":["Long-term use of methotrexate does not result in hepatitis B reactivation in rheumatologic patients"],"prefix":"10.1007","volume":"9","author":[{"given":"Charlie","family":"Laohapand","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Emvalee","family":"Arromdee","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Tawesak","family":"Tanwandee","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2015,1,15]]},"reference":[{"key":"9597_CR1","doi-asserted-by":"crossref","first-page":"47","DOI":"10.1055\/s-2003-37590","volume":"23","author":"G Fattovich","year":"2003","unstructured":"Fattovich G. Natural history and prognosis of hepatitis B. Semin Liver Dis 2003;23:47\u201358","journal-title":"Semin Liver Dis"},{"key":"9597_CR2","doi-asserted-by":"crossref","first-page":"17","DOI":"10.1055\/s-2004-828674","volume":"24","author":"BJ McMahon","year":"2004","unstructured":"McMahon BJ. The natural history of chronic hepatitis B virus infection. Semin Liver Dis 2004;24:17\u201321","journal-title":"Semin Liver Dis"},{"key":"9597_CR3","doi-asserted-by":"crossref","first-page":"130","DOI":"10.1055\/s-2006-939751","volume":"26","author":"SJ Hadziyannis","year":"2006","unstructured":"Hadziyannis SJ, Papatheodoridis GV. Hepatitis B e antigen-negative chronic hepatitis B: natural history and treatment. Semin Liver Dis 2006;26:130\u2013141","journal-title":"Semin Liver Dis"},{"key":"9597_CR4","doi-asserted-by":"crossref","first-page":"335","DOI":"10.1016\/j.jhep.2007.11.011","volume":"48","author":"G Fattovich","year":"2008","unstructured":"Fattovich G, Bortolotti F, Donato F. Natural history of chronic hepatitis B: special emphasis on disease progression and prognostic factors. J Hepatol 2008;48:335\u2013352","journal-title":"J Hepatol"},{"key":"9597_CR5","doi-asserted-by":"crossref","first-page":"84","DOI":"10.1136\/gut.2007.128496","volume":"57","author":"G Fattovich","year":"2008","unstructured":"Fattovich G, Olivari N, Pasino M, D\u2019Onofrio M, Martone E, Donato F. Long-term outcome of chronic hepatitis B in Caucasian patients: mortality after 25\u00a0years. Gut 2008;57:84\u201390","journal-title":"Gut"},{"key":"9597_CR6","doi-asserted-by":"crossref","first-page":"535","DOI":"10.1053\/j.gastro.2004.09.014","volume":"127","author":"G Fattovich","year":"2004","unstructured":"Fattovich G, Stroffolini T, Zagni I, Donato F. Hepatocellular carcinoma in cirrhosis: incidence and risk factors. Gastroenterology 2004;127:535\u2013550","journal-title":"Gastroenterology"},{"key":"9597_CR7","doi-asserted-by":"crossref","first-page":"652","DOI":"10.1016\/j.jhep.2008.07.014","volume":"49","author":"G Raimondo","year":"2008","unstructured":"Raimondo G, Allain JP, Brunetto MR, Buendia MA, Chen DS, Colombo M, et al. Statements from the Taormina expert meeting on occult hepatitis B virus infection. J Hepatol 2008;49:652\u2013657","journal-title":"J Hepatol"},{"key":"9597_CR8","doi-asserted-by":"crossref","first-page":"1631","DOI":"10.1097\/01.TP.0000163468.80223.74","volume":"79","author":"A Knoll","year":"2005","unstructured":"Knoll A, Pietrzyk M, Loss M, Goetz WA, Jilq W. Solid-organ transplantation in HBsAg-negative patients with antibodies to HBV core antigen: low risk of HBV reactivation. Transplantation 2005;79:1631\u20131633","journal-title":"Transplantation"},{"key":"9597_CR9","first-page":"231","volume":"28","author":"P Marcellin","year":"1991","unstructured":"Marcellin P, Giostra E, Martinot-Peignoux M, Loriot MA, Jaegle ML, Wolf P, et al. Redevelopment of hepatitis-B surface-antigen after renal-transplantation. Gastroenterology 1991;28:231\u2013236","journal-title":"Gastroenterology"},{"key":"9597_CR10","doi-asserted-by":"crossref","first-page":"182","DOI":"10.1016\/0016-5085(91)90599-G","volume":"100","author":"AS Lok","year":"1991","unstructured":"Lok AS, Liang RH, Chiu EK, Wong KL, Chan TK, Todd D. Reactivation of hepatitis B virus replication in patients receiving cytotoxic therapy, report of a prospective study. Gastroenterology 1991;100:182\u2013188","journal-title":"Gastroenterology"},{"key":"9597_CR11","doi-asserted-by":"crossref","first-page":"1076","DOI":"10.1016\/j.cgh.2006.05.027","volume":"4","author":"AL Mindikoglu","year":"2006","unstructured":"Mindikoglu AL, Regev A, Schiff ER. Hepatitis B virus reactivation after cytotoxic chemotherapy: the disease and its prevention. Clin Gastroenterol Hepatol 2006;4:1076\u20131081","journal-title":"Clin Gastroenterol Hepatol"},{"key":"9597_CR12","doi-asserted-by":"crossref","first-page":"762","DOI":"10.1002\/art.23721","volume":"59","author":"KG Saag","year":"2008","unstructured":"Saag KG, Teng GG, Patkar NM, Anuntiyo J, Finney C, Curtis JR, et al. American College of Rheumatology 2008 recommendations for the use of nonbiologic and biologic disease modifying antirheumatic drugs in rheumatoid arthritis. Arthritis Rheum 2008;59:762\u2013784","journal-title":"Arthritis Rheum"},{"key":"9597_CR13","doi-asserted-by":"crossref","first-page":"381","DOI":"10.7326\/0003-4819-112-5-381","volume":"112","author":"MA Flowers","year":"1990","unstructured":"Flowers MA, Heathcote J, Wanless IR, Sherman M, Reynolds WJ, Cameron RG, et al. Fulminant hepatitis as a consequence of reactivation of hepatitis B virus infection after discontinuation of low dose methotrexate therapy. Ann Intern Med 1990;112:381\u2013382","journal-title":"Ann Intern Med"},{"key":"9597_CR14","first-page":"2037","volume":"25","author":"J Narva\u00e9z","year":"1998","unstructured":"Narva\u00e9z J, Rodriguez-Moreno J, Martinez-Aguila MD, Clavaguera MT. Severe hepatitis linked to B virus infection after withdrawal of low dose methotrexate therapy. J Rheumatol 1998;25:2037\u20132038","journal-title":"J Rheumatol"},{"key":"9597_CR15","doi-asserted-by":"crossref","first-page":"339","DOI":"10.1002\/1529-0131(200102)44:2<339::AID-ANR51>3.0.CO;2-Q","volume":"44","author":"S Ito","year":"2001","unstructured":"Ito S, Nakazono K, Murasawa A, Mita Y, Hata K, Saito N, et al. Development of fulminant hepatitis B (precore variant mutant type) after the discontinuation of low-dose methotrexate therapy in a rheumatoid arthritis patient. Arthritis Rheum 2001;44:339\u2013342","journal-title":"Arthritis Rheum"},{"key":"9597_CR16","first-page":"375","volume":"22","author":"H Hagiyama","year":"2004","unstructured":"Hagiyama H, Kubota T, Komano Y, Kurosaki M, Watanabe M, Miyasaka N. Fulminant hepatitis in an asymptomatic chronic carrier of hepatitis B virus mutant after withdrawal of low-dose methotrexate therapy for rheumatoid arthritis. Clin Exp Rheumatol 2004;22:375\u2013376","journal-title":"Clin Exp Rheumatol"},{"key":"9597_CR17","doi-asserted-by":"crossref","first-page":"470","DOI":"10.3109\/s10165-011-0521-9","volume":"22","author":"K Watanabe","year":"2012","unstructured":"Watanabe K, Takase K, Ohno S, Ideguchi H, Nozaki A, Ishigatsubo Y. Reactivation of hepatitis B virus in a hepatitis B surface antigen-negative patient with rheumatoid arthritis treated with methotrexate. Mod Rheumatol 2012;22:470\u2013473","journal-title":"Mod Rheumatol"},{"key":"9597_CR18","first-page":"609","volume":"42","author":"N Chimparlee","year":"2011","unstructured":"Chimparlee N, Oota S, Phikulsod S, Tangkijvanich P, Poovorawan Y. Hepatitis B and hepatitis C virus in Thai blood donors. Southeast Asian J Trop Med Public Health 2011;42:609\u2013615","journal-title":"Southeast Asian J Trop Med Public Health"},{"key":"9597_CR19","doi-asserted-by":"crossref","first-page":"389","DOI":"10.1016\/S1665-2681(19)31844-7","volume":"7","author":"M Srisupanant","year":"2008","unstructured":"Srisupanant M, Wiwanitkit V. Prevalence of hepatitis B seropositivity among Thai workers in screening program before going abroad. Ann Hepatol. 2008;7:389","journal-title":"Ann Hepatol"},{"key":"9597_CR20","doi-asserted-by":"crossref","first-page":"1496","DOI":"10.1111\/j.1365-3156.2006.01709.x","volume":"11","author":"V Chongsrisawat","year":"2006","unstructured":"Chongsrisawat V, Yoocharoen P, Theamboonlers A, Tharmaphornpilas P, Warinsathien P, Sinlaparatsamee S, et al. Hepatitis B seroprevalence in Thailand: 12\u00a0years after hepatitis B vaccine integration into the national expanded programme on immunization. Trop Med Int Health 2006;11:1496\u20131502","journal-title":"Trop Med Int Health"},{"key":"9597_CR21","first-page":"45","volume":"38","author":"P Luksamijarulkul","year":"2007","unstructured":"Luksamijarulkul P, Kaepan W, Klamphakorn S. Hepatitis B virus sero-markers, hepatitis C virus antibody and risk behaviors among middle age and older Thai males. Southeast Asian J Trop Med Public Health 2007;38:45\u201352","journal-title":"Southeast Asian J Trop Med Public Health"},{"key":"9597_CR22","doi-asserted-by":"crossref","first-page":"576","DOI":"10.1016\/j.ejim.2011.09.002","volume":"22","author":"M Marignani","year":"2011","unstructured":"Marignani M, Canzoni M, D\u2019Amelio R, Santis ED, Pecchioli A, Fave GD. Should we routinely treat patients with autoimmune\/rheumatic diseases and chronic hepatitis B virus infection starting biologic therapies with antiviral agents? No. Eur J Intern Med 2011;22:576\u2013581","journal-title":"Eur J Intern Med"}],"container-title":["Hepatology International"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s12072-014-9597-6.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/article\/10.1007\/s12072-014-9597-6\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s12072-014-9597-6","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2019,8,19]],"date-time":"2019-08-19T14:09:24Z","timestamp":1566223764000},"score":1,"resource":{"primary":{"URL":"http:\/\/link.springer.com\/10.1007\/s12072-014-9597-6"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2015,1,15]]},"references-count":22,"journal-issue":{"issue":"2","published-print":{"date-parts":[[2015,4]]}},"alternative-id":["9597"],"URL":"https:\/\/doi.org\/10.1007\/s12072-014-9597-6","relation":{},"ISSN":["1936-0533","1936-0541"],"issn-type":[{"value":"1936-0533","type":"print"},{"value":"1936-0541","type":"electronic"}],"subject":[],"published":{"date-parts":[[2015,1,15]]}}}